Ibere Pharmaceuticals (NYSE: IBER)
Ibere Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ibere Pharmaceuticals Company Info
Ibere Pharmaceuticals, which manages internationally known brands and develops clinical assets through food and drug administration through commercialization, develops and applies technologies with industry-wide commercial applications.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.